Protest against P&ID
These protestors are marching against the judgment of a British court which granted P&ID powers to seize at least $9.6 billion of Nigeria's asset.…
Why Amgen thinks Celgene’s Psoriasis drug Otezla is worth $13.4 Billion
Amgen Inc. will pay $13.4 billion for a blockbuster psoriasis drug from Celgene Corp., which is shedding the asset in order to win antitrust regulators’ sign-off for its $74 billion merger with…